| 1 | [SID99495037] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 2 | [SID99495037] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 3 | [SID99495037] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624126, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624126 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 4 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 5 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 6 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 7 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 8 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 9 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 10 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 11 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 12 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 13 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 14 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624038, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624038 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 15 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 16 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 17 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 18 | [SID99495037] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 19 | [SID99495037] | Inactive | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 20 | [SID99495037] | Inactive | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 21 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 22 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 23 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 24 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 25 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists [AID624463, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists | | AID | 624463 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 26 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 27 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 28 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 29 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 30 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators [AID624464, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators | | AID | 624464 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 31 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 32 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 33 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 34 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 35 | [SID99495037] | Inactive | | | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists [AID624465, Type: other] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists | | AID | 624465 | | BioAssay type | other | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 36 | [SID99495037] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 37 | [SID99495037] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 38 | [SID99495037] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 39 | [SID99495037] | Inactive | | | qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Agonist: qHTS | | AID | 652048 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 40 | [SID99495037] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 41 | [SID99495037] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 42 | [SID99495037] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 43 | [SID99495037] | Inactive | | | qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening] | DRD3 gene product [Homo sapiens] [gi:89191863] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | qHTS of D3 Dopamine Receptor Potentiators: qHTS | | AID | 652051 | | BioAssay type | screening | | Target | DRD3 gene product [Homo sapiens] [gi:89191863] | | PubMed | | | Data Table |  |
|
| 44 | [SID99495037] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID99495037] | Inactive | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID99495037] | Inactive | | | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity [AID588436, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity | | AID | 588436 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID99495037] | Inactive | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID99495037] | Inactive | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID99495037] | Inactive | | | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors [AID602141, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | BioAssay | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors | | AID | 602141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID99495037] | Inactive | Potency | | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 99495037 | | CID | 46948371 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|